These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10090108)

  • 1. Antihypertensives: much ado about lipids.
    Golomb BA; Criqui MH
    Arch Intern Med; 1999 Mar; 159(6):535-7. PubMed ID: 10090108
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: the effects of antihypertensive agents on serum lipids.
    Madu EC; Reddy RC; Madu AN; Anyaogu C; Harris T; Fraker TD
    Am J Med Sci; 1996 Aug; 312(2):76-84. PubMed ID: 8701970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 4. Will ASCOT change the form of anti-hypertensive therapy?
    Bilous R
    Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular risk profile and use of statins at the age of 70 years: a comparison of two Finnish birth cohorts born 20 years apart.
    Upmeier E; Vire J; Korhonen MJ; Isoaho H; Lehtonen A; Arve S; Wuorela M; Viitanen M
    Age Ageing; 2016 Jan; 45(1):84-90. PubMed ID: 26764397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid lowering strategies.
    Morrell J
    Indian Heart J; 1999; 51(5):489-93. PubMed ID: 10721637
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary prevention of cardiovascular diseases by lowering lipids].
    Klose G
    Internist (Berl); 1997 Jun; 38(6):615-6. PubMed ID: 9265009
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolution of antihypertensive therapy: current theoretical conditions and individualized treatment options.
    Weber MA
    Am J Med; 1992 Aug; 93(2A):1S-3S. PubMed ID: 1519632
    [No Abstract]   [Full Text] [Related]  

  • 9. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipids and Cardiovascular Disease: Putting It All Together.
    Pownall HJ; Gotto AM
    Methodist Debakey Cardiovasc J; 2019; 15(1):5-8. PubMed ID: 31049143
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive therapy and plasma lipids.
    Shaw J
    Med J Aust; 1984 Apr; 140(9):517-8. PubMed ID: 6708892
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of antihypertensive agents on serum lipids and lipoproteins.
    Chait A
    Am J Med; 1989 Jan; 86(1B):5-7. PubMed ID: 2913771
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antihypertensive agents and serum lipids].
    Helgeland A
    Tidsskr Nor Laegeforen; 1981 Sep; 101(25):1406-7. PubMed ID: 6122289
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting levels and functions of blood lipids in the prevention of CVD.
    Mearns BM
    Nat Rev Cardiol; 2011 Apr; 8(4):179-80. PubMed ID: 21436841
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chinese expert consensus on blood lipid related cardiovascular residual risk control].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jul; 40(7):547-53. PubMed ID: 22943680
    [No Abstract]   [Full Text] [Related]  

  • 16. ASCOT a four horse race.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):51-4. PubMed ID: 16470483
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipidology.
    Nicholls SJ
    Cardiol Clin; 2018 May; 36(2):xiii. PubMed ID: 29609763
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of lipids in the elderly.
    Winder A
    J R Soc Med; 1998 Apr; 91(4):189-91. PubMed ID: 9659303
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing cardiovascular risk reduction during antihypertensive therapy.
    Weinberger MH
    Hypertension; 1990 Aug; 16(2):201-11. PubMed ID: 2143173
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.
    Tziomalos K; Athyros VG; Mikhailidis DP; Karagiannis A
    Curr Pharm Des; 2013; 19(21):3766-72. PubMed ID: 23286433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.